Publications 2009

Bachoud-Lévi A-C. Neural grafts in Huntington’s disease: viability after 10 years (Invited review). Lancet Neurol, 2009, Nov;8(11):979-81

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain, 2009, Jan;132(Pt 1):156-71. Epub 2008 Nov 23.PMID

Bourlon C, Chokron S, Bachoud-Lévi A-C, Coubard O, Bergeras I, Moulignier A, Viret AC, Bartolomeo P. Presentation of an assessment battery for visual mental imagery and visual perception.] Rev Neurol (Paris), 2009, May 30.

Bousser M-G, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M-G, Mattle H-P, Rothwell P-M; PERFORM Study Investigators. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovasc Dis, 2009,27(5):509-18. Epub 2009 Apr 16.PMID [The future for nerve cell transplantation?]

Cesaro P, Fénelon G, Remy P. [Biotherapies in Parkinson’s disease]. Rev Neurol (Paris), 2009,165: 857-62. [in French]

Cleret de Langavant L, Trinkler I, Cesaro P, Bachoud-Lévi A-C. Heterotopagnosia: When I point at parts of your body. Neuropsychologia, 2009, Jun;47(7):1745-55. Epub 2009 Feb 14.

Couette M, Boisse M-F, Maison P, Brugières P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Lévi A-C *, Authier F-J *. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. * Both authors contribute equally to the study J Inorg Biochem.,2009, Nov;103(11):1571-8

Devos D; French DUODOPA Study Group. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson’s disease. Mov Disord, 2009, May 15; 24(7):993-1000.

Dhanens CM; Burnouf S; Simonin C; Vanbrussel E; Duhamel A; Defebvre L; Duru C; Vuillaume I; Cazeneuve C; Charles P; Maison P; Debruxelles S; Verny C; Gervais H; Azulay JP; Tranchant C; Bachoud-Lévi A-C; Dürr A; Buée L; Krystkowiak P; Sablonnière B, Blum D on behalf the Huntington French Speaking Network. A genetic variation in the ADORA2A gene modifies age at onset in Huntington’s disease. Neurobiol Dis.,2009, Sep;35(3):474-6. Epub 2009 Jul 8

Diederich NJ, Fénelon G, Stebbins G, Goetz C-G. Hallucinations in Parkinson disease. Nat Rev Neurol2009 Jun;5(6):331-42.

Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud-Lévi A-C, Hantraye P, Remy P.In vivo evidence for the selective subcortical degeneration in Huntington’s disease. Neuroimage. 2009 Jul 15;46(4):958-66. Epub, 2009, Mar 28.

Itti E, Villafane G, Malek Z, Brugières P, Capacchione D, Itti L, Maison P, Cesaro P, Meignan M. Dopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson’s disease: an observational study. Nucl Med Commun, 2009, Jul;30(7):513-8.

Lefaucheur JP, Drouot X, Cunin P, Bruckert R, Lepetit H, Créange A, Wolkenstein P, Maison P, Keravel Y, Nguyen JP. Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain. Brain. 2009 Jun;132(Pt 6):1463-71. Epub, 2009, Mar 31.PMID:

Maison P, Walker D-J, Walsh F-S, Williams G, Doherty PBDNF regulates neuronal sensitivity to endocannabinoids. Neurosci Lett.,2009, Dec 25;467(2):90-4. Epub, 2009, Oct 8.PMID:

Olanow CW, Rascol O, Hauser R, Feigin P-D, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E; ADAGIO Study Investigators. A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med, 2009, Sep 24;361(13):1268-78.PMID: 1977640

Rodriguez-Fornells, A., Cunillera, T., Mestres-Missé, A., de Diego-Balaguer, R. Neurophysiological mechanisms involved in language learning in adults. Philosophical Transactions of the Royal Society B-Biological Sciences, 2009, 364, 3711-3735.

Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay JP, Tranchant C, Broussolle E, Morin F, Bachoud-Lévi A-C, Maison P. Neuroendocrine disturbances in Huntington’s disease. PLoS One, 2009,4(3): e4962. Epub 2009 Mar 25

Teichmann M, Darcy I, Bachoud-Lévi A-C, Dupoux E. The role of the striatum in phonological processing. Evidence from early stages of Huntington’s disease. Cortex, 2009, Jul-Aug; 45(7): 839-49.

Trinkler I, King JA, Doeller CF, Rugg MD, Burgess N. Neural bases of autobiographical support for episodic recollection of faces. Hippocampus, 2009,19(8): 718-30